168 related articles for article (PubMed ID: 22914648)
1. Increased expression and aberrant localization of mucin 13 in metastatic colon cancer.
Gupta BK; Maher DM; Ebeling MC; Sundram V; Koch MD; Lynch DW; Bohlmeyer T; Watanabe A; Aburatani H; Puumala SE; Jaggi M; Chauhan SC
J Histochem Cytochem; 2012 Nov; 60(11):822-31. PubMed ID: 22914648
[TBL] [Abstract][Full Text] [Related]
2. Functions and regulation of MUC13 mucin in colon cancer cells.
Gupta BK; Maher DM; Ebeling MC; Stephenson PD; Puumala SE; Koch MR; Aburatani H; Jaggi M; Chauhan SC
J Gastroenterol; 2014 Oct; 49(10):1378-91. PubMed ID: 24097071
[TBL] [Abstract][Full Text] [Related]
3. Expression and functions of transmembrane mucin MUC13 in ovarian cancer.
Chauhan SC; Vannatta K; Ebeling MC; Vinayek N; Watanabe A; Pandey KK; Bell MC; Koch MD; Aburatani H; Lio Y; Jaggi M
Cancer Res; 2009 Feb; 69(3):765-74. PubMed ID: 19176398
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of MUC13 in pancreatic ductal adenocarcinoma.
Khan S; Zafar N; Khan SS; Setua S; Behrman SW; Stiles ZE; Yallapu MM; Sahay P; Ghimire H; Ise T; Nagata S; Wang L; Wan JY; Pradhan P; Jaggi M; Chauhan SC
HPB (Oxford); 2018 Jun; 20(6):563-572. PubMed ID: 29352660
[TBL] [Abstract][Full Text] [Related]
5. MUC13 mucin augments pancreatic tumorigenesis.
Chauhan SC; Ebeling MC; Maher DM; Koch MD; Watanabe A; Aburatani H; Lio Y; Jaggi M
Mol Cancer Ther; 2012 Jan; 11(1):24-33. PubMed ID: 22027689
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of mucin 13 due to promoter methylation promotes aggressive behavior in ovarian cancer cells.
Sung HY; Park AK; Ju W; Ahn JH
Yonsei Med J; 2014 Sep; 55(5):1206-13. PubMed ID: 25048476
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of MUC13 is associated with intestinal-type gastric cancer.
Shimamura T; Ito H; Shibahara J; Watanabe A; Hippo Y; Taniguchi H; Chen Y; Kashima T; Ohtomo T; Tanioka F; Iwanari H; Kodama T; Kazui T; Sugimura H; Fukayama M; Aburatani H
Cancer Sci; 2005 May; 96(5):265-73. PubMed ID: 15904467
[TBL] [Abstract][Full Text] [Related]
8. MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways.
Tiemin P; Fanzheng M; Peng X; Jihua H; Ruipeng S; Yaliang L; Yan W; Junlin X; Qingfu L; Zhefeng H; Jian L; Zihao G; Guoxing L; Boshi S; Ming Z; Qinghui M; Desen L; Lianxin L
J Hepatol; 2020 Apr; 72(4):761-773. PubMed ID: 31837357
[TBL] [Abstract][Full Text] [Related]
9. The MUC13 cell surface mucin is highly expressed by human colorectal carcinomas.
Walsh MD; Young JP; Leggett BA; Williams SH; Jass JR; McGuckin MA
Hum Pathol; 2007 Jun; 38(6):883-92. PubMed ID: 17360025
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of MUC13, a Poor Prognostic Predictor, Promotes Cell Growth by Activating Wnt Signaling in Hepatocellular Carcinoma.
Dai Y; Liu L; Zeng T; Liang JZ; Song Y; Chen K; Li Y; Chen L; Zhu YH; Li J; Li Y; Xie D; Yuan YF; Guan XY
Am J Pathol; 2018 Feb; 188(2):378-391. PubMed ID: 29174628
[TBL] [Abstract][Full Text] [Related]
11. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274
[TBL] [Abstract][Full Text] [Related]
12. Transmembrane mucin MUC13 distinguishes intraductal papillary mucinous neoplasms from non-mucinous cysts and is associated with high-risk lesions.
Stiles ZE; Khan S; Patton KT; Jaggi M; Behrman SW; Chauhan SC
HPB (Oxford); 2019 Jan; 21(1):87-95. PubMed ID: 30115565
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of mucin gene expression in normal and neoplastic tissues.
Ho SB; Niehans GA; Lyftogt C; Yan PS; Cherwitz DL; Gum ET; Dahiya R; Kim YS
Cancer Res; 1993 Feb; 53(3):641-51. PubMed ID: 7678777
[TBL] [Abstract][Full Text] [Related]
14. Exploring the potential of mucin 13 (MUC13) as a biomarker for carcinomas and other diseases.
Filippou PS; Ren AH; Korbakis D; Dimitrakopoulos L; Soosaipillai A; Barak V; Frenkel S; Pe'er J; Lotem M; Merims S; Molina R; Blasutig I; Bogdanos DP; Diamandis EP
Clin Chem Lab Med; 2018 Oct; 56(11):1945-1953. PubMed ID: 29768245
[TBL] [Abstract][Full Text] [Related]
15. [Increased methylation of promotor region suppresses expression of MUC2 gene in colon carcinoma cells].
Riede E; Gratchev A; Foss HD; Mann B; Buhr HJ; Hanski C
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):299-302. PubMed ID: 14518264
[TBL] [Abstract][Full Text] [Related]
16. Reduction of miR‑132‑3p contributes to gastric cancer proliferation by targeting MUC13.
He L; Qu L; Wei L; Chen Y; Suo J
Mol Med Rep; 2017 May; 15(5):3055-3061. PubMed ID: 28339011
[TBL] [Abstract][Full Text] [Related]
17. Localization of mucin (MUC2 and MUC3) messenger RNA and peptide expression in human normal intestine and colon cancer.
Chang SK; Dohrman AF; Basbaum CB; Ho SB; Tsuda T; Toribara NW; Gum JR; Kim YS
Gastroenterology; 1994 Jul; 107(1):28-36. PubMed ID: 8020672
[TBL] [Abstract][Full Text] [Related]
18. Biophysical changes caused by altered MUC13 expression in pancreatic cancer cells.
Massey AE; Doxtater KA; Yallapu MM; Chauhan SC
Micron; 2020 Mar; 130():102822. PubMed ID: 31927412
[TBL] [Abstract][Full Text] [Related]
19. Mucins and mucin binding proteins in colorectal cancer.
Byrd JC; Bresalier RS
Cancer Metastasis Rev; 2004; 23(1-2):77-99. PubMed ID: 15000151
[TBL] [Abstract][Full Text] [Related]
20. Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis.
Bresalier RS; Niv Y; Byrd JC; Duh QY; Toribara NW; Rockwell RW; Dahiya R; Kim YS
J Clin Invest; 1991 Mar; 87(3):1037-45. PubMed ID: 1999484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
